ANSLY
Price
$79.49
Change
-$0.51 (-0.64%)
Updated
Jun 20 closing price
Capitalization
2.06B
BRSYF
Price
$3.40
Change
-$2.39 (-41.28%)
Updated
Apr 11 closing price
Capitalization
39.9M
Interact to see
Advertisement

ANSLY vs BRSYF

Header iconANSLY vs BRSYF Comparison
Open Charts ANSLY vs BRSYFBanner chart's image
Ansell
Price$79.49
Change-$0.51 (-0.64%)
Volume$150
Capitalization2.06B
Brainsway
Price$3.40
Change-$2.39 (-41.28%)
Volume$900
Capitalization39.9M
ANSLY vs BRSYF Comparison Chart in %
Loading...
ANSLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BRSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANSLY vs. BRSYF commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANSLY is a Hold and BRSYF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ANSLY: $79.49 vs. BRSYF: $3.40)
Brand notoriety: ANSLY and BRSYF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ANSLY: 111% vs. BRSYF: 100%
Market capitalization -- ANSLY: $2.06B vs. BRSYF: $39.9M
ANSLY [@Medical Specialties] is valued at $2.06B. BRSYF’s [@Medical Specialties] market capitalization is $39.9M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANSLY’s FA Score shows that 2 FA rating(s) are green whileBRSYF’s FA Score has 0 green FA rating(s).

  • ANSLY’s FA Score: 2 green, 3 red.
  • BRSYF’s FA Score: 0 green, 5 red.
According to our system of comparison, ANSLY is a better buy in the long-term than BRSYF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANSLY’s TA Score shows that 2 TA indicator(s) are bullish while BRSYF’s TA Score has 2 bullish TA indicator(s).

  • ANSLY’s TA Score: 2 bullish, 3 bearish.
  • BRSYF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, BRSYF is a better buy in the short-term than ANSLY.

Price Growth

ANSLY (@Medical Specialties) experienced а 0.00% price change this week, while BRSYF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.37%. For the same industry, the average monthly price growth was +1.95%, and the average quarterly price growth was +2.76%.

Industries' Descriptions

@Medical Specialties (+2.37% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANSLY($2.06B) has a higher market cap than BRSYF($39.9M). BRSYF YTD gains are higher at: 7.937 vs. ANSLY (-5.059). ANSLY has higher annual earnings (EBITDA): 274M vs. BRSYF (-13.7M). ANSLY has more cash in the bank: 86.1M vs. BRSYF (44.3M). BRSYF has less debt than ANSLY: BRSYF (754K) vs ANSLY (486M). ANSLY has higher revenues than BRSYF: ANSLY (1.78B) vs BRSYF (25.8M).
ANSLYBRSYFANSLY / BRSYF
Capitalization2.06B39.9M5,170%
EBITDA274M-13.7M-2,000%
Gain YTD-5.0597.937-64%
P/E Ratio13.99N/A-
Revenue1.78B25.8M6,891%
Total Cash86.1M44.3M194%
Total Debt486M754K64,456%
FUNDAMENTALS RATINGS
ANSLY vs BRSYF: Fundamental Ratings
ANSLY
BRSYF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
68
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8978
PRICE GROWTH RATING
1..100
5759
P/E GROWTH RATING
1..100
32100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANSLY's Valuation (6) in the null industry is somewhat better than the same rating for BRSYF (68). This means that ANSLY’s stock grew somewhat faster than BRSYF’s over the last 12 months.

ANSLY's Profit vs Risk Rating (100) in the null industry is in the same range as BRSYF (100). This means that ANSLY’s stock grew similarly to BRSYF’s over the last 12 months.

BRSYF's SMR Rating (78) in the null industry is in the same range as ANSLY (89). This means that BRSYF’s stock grew similarly to ANSLY’s over the last 12 months.

ANSLY's Price Growth Rating (57) in the null industry is in the same range as BRSYF (59). This means that ANSLY’s stock grew similarly to BRSYF’s over the last 12 months.

ANSLY's P/E Growth Rating (32) in the null industry is significantly better than the same rating for BRSYF (100). This means that ANSLY’s stock grew significantly faster than BRSYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANSLYBRSYF
RSI
ODDS (%)
Bearish Trend 4 days ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
38%
N/A
Momentum
ODDS (%)
Bearish Trend 4 days ago
46%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
48%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
41%
Bullish Trend 4 days ago
30%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
46%
Bullish Trend 4 days ago
30%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
31%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ANSLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BRSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OANGX36.150.39
+1.09%
Oakmark Global Institutional
ICMVX13.220.05
+0.38%
Intrepid Capital Institutional
SSVIX21.490.05
+0.23%
Columbia Select Small Cap Value Inst2
CNWAX87.770.19
+0.22%
American Funds New World 529A
FEGOX32.55-1.10
-3.27%
First Eagle Gold C

ANSLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANSLY has been loosely correlated with BRSYF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ANSLY jumps, then BRSYF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANSLY
1D Price
Change %
ANSLY100%
N/A
BRSYF - ANSLY
61%
Loosely correlated
N/A
VERO - ANSLY
38%
Loosely correlated
-0.91%
IOBCF - ANSLY
35%
Loosely correlated
N/A
FSPKF - ANSLY
22%
Poorly correlated
N/A
APYX - ANSLY
21%
Poorly correlated
-3.57%
More

BRSYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRSYF has been loosely correlated with ANSLY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if BRSYF jumps, then ANSLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRSYF
1D Price
Change %
BRSYF100%
N/A
ANSLY - BRSYF
61%
Loosely correlated
N/A
KSRBF - BRSYF
51%
Loosely correlated
N/A
VERO - BRSYF
28%
Poorly correlated
-0.91%
WUXIF - BRSYF
27%
Poorly correlated
N/A
FSPKF - BRSYF
25%
Poorly correlated
N/A
More